• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Lamotrigine versus carbamazepine in treating newly diagnosed epilepsy:A meta-analysis

    2014-07-02 01:45:40LIUYaPENGYaWenZHOUKeChengQUChengHaoHUWeiOutpatientDepartmentXijingHospitalFourthMilitaryMedicalUniversityofPLAXian700ChinaStudentBrigadeFourthMilitaryMedicalUniversityofPLAXian700ChinaResearchLaboratoryofChineseMe
    關(guān)鍵詞:阿東床邊阿里

    LIU Ya,PENG Ya-Wen,ZHOU Ke-Cheng,QU Cheng-Hao,HU WeiOutpatient Department,Xijing Hospital,F(xiàn)ourth Military Medical University of PLA,Xi'an 700,China;Student Brigade,F(xiàn)ourth Military Medical University of PLA,Xi'an 700,China;Research Laboratory of Chinese Medicine Compound,China Pharmaceutical University,Nanjing 98,China

    ·臨床與轉(zhuǎn)化醫(yī)學(xué)·

    Lamotrigine versus carbamazepine in treating newly diagnosed epilepsy:A meta-analysis

    LIU Ya1,PENG Ya-Wen2,ZHOU Ke-Cheng3,QU Cheng-Hao2,HU Wei21Outpatient Department,Xijing Hospital,F(xiàn)ourth Military Medical University of PLA,Xi'an 710032,China;2Student Brigade,F(xiàn)ourth Military Medical University of PLA,Xi'an 710032,China;3Research Laboratory of Chinese Medicine Compound,China Pharmaceutical University,Nanjing 211198,China

    First-line therapy for newly diagnosed epilepsy(e.g.carbamazepine)is generally considered effective.However,in a significant proportion of patients(especially in the elderly),usage may be limited by unwanted adverse events.To synthesize evidence regarding efficacy and tolerability of lamotrigine as first line,monotherapyorprophylacticantiepileptic.MEDLINE,

    PsycINFO,Scopus,EMBASE,and the Cochrane Central Register of Controlled Trials(CENTRAL)were searched from inception to June 2014.Randomised controlled trials(RCTs)comparing lamotrigine with carbamazepine monotherapy for newly diagnosed epilepsy.Eligible studies were independently selected and methodological quality was independently evaluated by two reviewers.Effects were summarized using standardized hazard ratio(HR)or odds ratio(OR)with suitable effect models.Pre-specified sensitivity analyses were performed to explain heterogeneity.Nine studies involving 2793 participants met the inclusion criteria.The effects of lamotrigine compared with carbamazepine in patients with newly diagnosed seizures were investigated in all studies.We found that carbamazepine was inferior in comparison to lamotrigine when measuring the proportion of remaining seizure free in the elderly(hazard ratio(HR)1.71;95%confidence interval(CI)

    1.27 to 2.29)but notthe children and the adult.There was strong evidence for the tolerability profile of lamotrigine compared with carbamazepine in the Retention rates(HR 1.67;95%CI 1.43 to 1.94).Moreover,lamotrigine lead to less adverse events.Lamotrigine and carbamazepine showed similar efficacy on newly diagnosed epilepsy but better efficacy in the elderly than carbamazepine.Furthermore,lamotrigine was better tolerated.

    lamotrigine;carbamazepine;newly diagnosed epilepsy;meta-analysis

    1 Introduction

    Standard first-line therapy for newly diagnosed epi-lepsy,e.g.carbamazepine(CBZ),is generally considered effective.However,in a significant proportion of patients,especially in the elderly,usage may be limited by unwanted adverse events.

    Lamotrigine(LTG)is a kind of benzene thiazine derivatives,the chemical properties differ from other new antiepileptic drugs.Experimental results suggested that LTG inhibits amyl four nitrogen and electrical stimulation of convulsion,shorten lesions,cortex and hippocampus excited after the discharge time,against part and generalized epilepsy.The drug effect was suggested to be mediated via multiple mechanisms:(1)inhibiting voltage dependent II type a sodium channel,stabilizing cell membrane to prevent abnormal discharge;(2)Stablizing presynaptic membrane,thus preventing evoked excitatory neurotransmitter release(especially glutamate);(3)inhibiting voltage dependent calcium channel.LTG has been used to control various types of epilepsy,including simple partial onset seizure,complex partial onset seizure,and secondary body stiffness seizure.However,whether it can be used to treat newly diagnosed epilepsy is not concluded.In some previous RCTs(randomized controlled trial),the efficacy of LTG in treating newly diagnosed epilepsy compared with CBZ was investigated,however,without consolidated conclusion.

    We thus performed the current meta-analysis of published and unpublished RCTs in which the efficacy and tolerability of CBZ and LTG,as monotherapy,were compared in patients with newly diagnosed epilepsy.Since the methodologies used and the patients recruited were similar in these studies,we compared these overall estimates between LTG and CBZ,allowing a broad estimate of their comparative efficacy and tolerability.Through comparison,the best comparative data available on these drugs to date can be provided(though in no way replacing RCTs comparing active treatments).A systematic approach and statistical synthesis of available data seems least“bad”at this time and a better approach than only reliance on the views of“opinion leaders”.

    2 Methods

    We performed the current meta-analysis based on the QUORUM guidelines[1](Quality of Reporting of Meta-analyses)and the recommendations of the Cochrane Collaboration[2].

    2.1 Data sources and searches The electronic databases screened were MEDLINE(1990 to September 2014),PsycINFO(1990 to September 2014),Scopus (1988 to September 2014),EMBASE(1990 to September 2014),and The Cochrane Library(Issue 9 of 12,September 2014),including the Cochrane Central Register of Controlled Trials(CENTRAL),Cochrane Database of Systematic Reviews(CDSR),Database of Abstracts of Reviews of Effects(DARE),and Health Technology Assessments(HTA).Searches were limited to human and performed for all languages,year of publication and type of publication.The key words,epilepsy and LTG,were used in combination with RCT or controlled clinical trial or review.Limiting the number of reports with a filter did not seem reasonable considering the potential number of studies,thus we did not use a filter such as the highly sensitive search strategy.The procedure of study selection was demonstrated in Fig.1 and two of us manually and independently screened reference sections of relevant original articles,reviews,and meta-analyses,leading to the inclusion of a total of 9 RCTs in this analysis.

    2.2 Analyzed studies Studies were included according to the following criteria:LTG were applied to treat the newly diagnosed epilepsy;Any RCT,controlled clinical trial,or open label trial(OLT)designed with a control group receiving first-line treatment drugs for epilepsy;and another group receiving LTG.

    The literature search yielded 116 citations.Initially,40 publications met our inclusion criteria.The excluded 76 publications were not about the newly diagnosed epilepsy.On more detailed review,an additional 16 papers were excluded because the comparison between LTG and CBZ were not performed.Then,another 5 papers were excluded because the focus of these studies was not onefficacy or tolerability of both drugs.Ten more publications were further excluded because of repeated or deficiency data(the repeated and deficiency data was derived from the abstract published on Epilepsia).The remained 9 studies[3-11]met our selection criteria and were included in the meta-analysis and their characteristics were presented in table 1.In total,1744 patients were randomly assigned to receive any form of oral administration of LTG,1393 were assigned to CBZ groups.

    Fig.1 Study selection

    2.3 Data Extraction Two reviewers independently screened the titles and abstracts of potentially eligible studies.The full text articles were examined independently by 2 of us to determine whether they met the inclusion criteria.Two of us independently extracted data (study characteristics and results)using data extraction forms,and then the collected data were entered into RevMan 5.0 using the double-entry system.Point estimates for selected variables were extracted and checked by other 2 reviewers.All discrepancies were recheckedand consensus was achieved by discussion with a third author involved.A record of reasons for excluding studies was kept.Cohen's kappa was applied for calculating inter-rater agreement.

    2.4 Outcome measures Based on the outcome measurements reported in the RCTs,we stratified main outcomes including withdrawal rate,retention rate,proportion of remaining seizure free,the time to first attack,the time to withdrawal and adverse effects.

    2.4.1 Efficacy:efficacy was evaluated by the primary outcome withdrawal rate and retention rate.Furthermore,proportion of remaining seizure free,the time to first attack and the time to withdrawal were recorded.

    2.4.2 Tolerability:tolerability was measured with the withdrawal rate,retention rate and the time to withdrawal.

    2.4.3 Adverse effects(AEs):rash,dizziness,headache,somnolence,fatigue,nausea and vomiting,diarrhea and poor coordination were included.Furthermore,the number of patients experiencing any AEs was recorded.

    The Jadad test(5 items)[12]was applied to assess methodological quality as high(score 5),moderate (score 4),or low(scores 1-3).

    2.5 Statistical analysis Because most outcomes were presented as incontinuous data,we used either the hazard ratios(HRs)or odds ratios(ORs)with 95%confidence intervals(CI)as effect measures.HRs were used to evaluate the time to first attack and the time to withdrawal.ORs as well as their 95%CIs were calculated.Data were analyzed using Review Manager Analyses software(RevMan 5.0.25)according to Cochrane Handbook for Systematic Reviews of Interventions.

    A sensitivity analysis was conducted to determine whether the meta conclusion were influenced by including low Jadad score papers.

    Publication bias may lead to asymmetrical funnel plots[13].Visual assessment of the funnel plot calculated by RevMan Analyses software was used to investigate the potential publication bias(i.e.,the association of publication probability with the statistical significance of study results).

    3 Results

    3.1 Baseline characteristics The baseline demographic characteristics,dosage of LTG and CBZ,exclusion criteria,and Jadad score for every study were demonstrated in Table 1.

    Table 1 Main study characteristics

    3.2 The time to first attack,withdrawal or retention The time to first attack or withdrawal were presented in Fig.3.Due to the lack of data,we could not build the survival curve;we just listed the currently a-vailable data from individual studies.Although no confirmative conclusion can be reached,LTG treatment led to longer time to withdrawal or the first attack,suggesting that the efficacy of LTG might be better than that of CBZ.

    The higher retention rate of LTG also showed its advantages over CBZ(OR,1.67(95%CI,1.43 to 1.94;P<0.000 01)).Furthermore,as can be seen from Fig.3,LTG had much more efficacy and tolerability in the elderly[OR,2.21(95%CI,1.64 to 2.98;P<0.000 01)]and adult[OR,1.53(95%CI,1.28 to 1.84;P<0.000 01)]than the children[OR,1.12 (95%CI,0.51 to 2.46;P=0.78)].

    Fig.2a Risk of bias graphFig.2 b Risk of bias summary

    3.3 Seizure free rate A moderate influence of LTG on the seizure free rate was revealed in the adult(Fig.4).Overall,LTG significantly increased the seizure free rate in the elderly[OR,1.71(95% CI,1.28 to 2.30;P=0.000 3)]but not the adult[OR,1.04 (95%CI,0.75 to 1.46;P=0.80].However,LTG treatment insignificantly decrease the seizure free rate in children[OR,0.73(95%CI,0.41 to 1.28;P=0.27)].

    Fig.3 Summary the efficacy

    Fig.4 Seizure free during different time

    3.4 The withdrawal Figure 5 demonstrated the strong evidence for the safety of oral LTG in treating the newly diagnosed epilepsy.LTG significantly reduced the withdrawal for any cause,all the events and rash[OR,0.54(95%CI,0.46 to 0.63;P<0.000 01);OR,0.41(95%CI,0.32 to 0.52;P<0.000 01);and OR,0.36(95%CI,0.24 to 0.55;P<0.000 01)],respectively.Concerning the withdrawal for all causes and AEs,LTG was considered as no significant advantage over CBZ in the children[OR,0.89(95%CI,0.41 to 1.96;P=0.78);OR,0.41(95%CI,0.32 to 0.52;P=0.62)],but LTG was better in the adult [OR,0.57(95%CI,0.47 to 0.68;P<0.000 01);OR,0.43(95%CI,0.33 to 0.57;P<0.000 01)]and the elderly[OR,0.45(95%CI,0.34 to 0.61;P<0.000 01);OR,0.32(95%CI,0.20 to 0.51;P<0.000 01)].

    In addition,the withdraw for rash was also significantly decreased in LTG than CBZ in the adult and elderly[OR,0.43(95% CI,0.33 to 1.57;P<0.000 01);OR,0.32(95%CI,0.20 to 0.51;P<0.000 01)]respectively.

    Fig.5 The withdrawal

    3.5 The adverse events The AEs of LTG and CBZ were summarized in Fig 6.Seven studies[3-5,7-8,10-11]reported adverse events data including the number of patients experiencing any AE,rash,dizziness,headache,somnolence,fatigue,nausea or vomiting,diarrhea,poor coordination compared to CBZ in a total of 2359 patients.Strong evidence was obtained that the LTG didn't increase the incidence of any AE[OR,0.62;(95%CI,0.44 to 0.87,P=0.006)],rash[OR,0.45;(95%CI,0.26 to 0.80,P<0.000 1)],somnolence[OR,0.33;(95%CI,0.20 to 0.54,P=0.87)],fatigue[OR,0.58;(95%CI,0.44 to 0.76,P<0.000 1)],poor co-ordination[OR,0.25;(95% CI,0.13 to 0.47,P<0.000 1)].However,there is high heterogeneity detected between studies in rash(I2 =72%,P=0.006)and somnolence(I2=60%,P<0.000 1).

    Fig.6 The AEs

    The outcome of the number of adult experiencing any AE showed LTG was safer than CBZ[OR,0.61;(95%CI,0.40 to 0.93,P=0.02)].

    Moreover,LTG significantly decreased rate of rash [OR,0.50;(95%CI,0.26 to 0.96,P=0.04)],somnolence[OR,0.33;(95%CI,0.20 to 0.54,P<0.000 1)]or fatigue[OR,0.54;(95%CI,0.41 to 0.73,P<0.000 1)]in the adult.In the children,the dizziness(OR,0.04;95%CI,0.00 to 0.29,P=0.002)and headache(OR,0.43;95%CI,0.18 to 1.01,P=0.05)were significantly decreased by LTG treatment.

    3.6 Bias assessment Summary assessment of the risk of bias tables is presented in Fig.2a,F(xiàn)ig.2b and Fig.3.High risk of bias might be derived from the study of Selim [14]because incomplete outcome data were given due to the lack of control group.Funnel plots for subgroup analysis assessing AEs revealed a symmetric distribution suggesting no publication bias(Fig.4).However,other funnel plots could not be provided because the data from included studies in each comparison group were inadequate.

    4 Discussion

    LTG has wide therapeutic spectra,fewer sideeffects,and lesser drug-to-drug interactions compared with the older typical antiepileptic drugs,thus has been used to treat some kinds of epilepsy,but seldom used in treating the newly diagnosed epilepsy.We performed the current meta-analysis to address whether LTG is superior to CBZ in treating newly diagnosed epilepsy.Through the analysis of the nine articles,we can come to the preliminary conclusion that LTG at least have the same curative effect with CBZ and a better tolerability than CBZ.However,the high heterogeneity of the current RCTs can not be ignored.We think,more studies should be done in the Europe and in every country independently,not multicenter.And this indicates LTG doesn't have the same efficacy and tolerability on patients from different countries in the Europe.It will be a significant measure to clear up this matter.Similarly more studies need to be done both in Asia and in America.We cannot reach reliable conclusion just by the limited studies.

    Old age is the most common time to develop the seizure disorder.In elderly patients,there is a particu-lar need to avoid central nervous system adverse events,which have been linked to increased risk of falls[15].Furthermore,the management of epilepsy in old patients is complicated by interactions between many well-established anti-epileptic drugs and treatments used for concomitant conditions.Unlike other antiepileptic treatments,LTG does not inhibit or induce hepatic enzymes,so reducing the potential for drug interactions[16].LTG shows more remarkable advantage over CBZ in the elderly and children than the adult.Its advantage has been convinced in the elderly,however,it need more studies to be supported.

    During this study,we also found some other conclusions about the newly diagnosed epilepsy treated by LTG.Bonnett L et al found that the sex was a significant factor that influences the time to 12 months of remission [17].Saetre E et al studied the quality of life in the elderly treated with antiepileptic drugs.The finding showed neither LTG nor CBZ seemed likely to cause significant changes in health-related quality of life measures after 40 weeks at therapeutic doses[11,18].However RUTH GILLHAM et al concluded that LTG offers the newly diagnosed patient with partial and/or generalized tonicclonic seizures significant benefits of greater tolerability and better quality of life,compared with CBZ[19].We think there are more trails needed conducting to study this question.In an international randomized doubleblind 40-week trial,Saetre E et al demonstrated clinically significant ECG changes were not common during treatment with CBZ or LTG in elderly patients with no preexisting significant AV conduction defects[20].Hussein Z and Posner J compared the oral clearance between Asians and Caucasian;it was lower in Asians than Caucasian[21].We can infer that the efficacy and tolerability among patients also differ in different districts.This also reminds us more studies are needed in different districts separately.

    There are also some other studies comparing LTG with other antiepileptic.There were no significant differences with regard to efficacy and tolerability of LEV(levetiracetam)and LTG in newly diagnosed focal and generalised epilepsy in Rosenow F et al's study[22].LTG had similar tolerability and seemed to have better efficacy to pregabalin for the treatment of newly diagnosed partial seizures in adults in Kwan P et al's study[23].Ethosuximide and valproic acid were more effective than LTG in the treatment of childhood absence epilepsy and ethosuximide was associated with fewer adverse attentional effects in Glauser TA et al's study[24].No difference in efficacy was found between sodium valproate and LTG in the patients with newly diagnosed epilepsy,however,LTG appeared to be better tolerated in Stephen LJ et al's study[25].Brodie MJ et al reached the conclusion that gabapentin and LTG monotherapy were similarly effective and well tolerated in patients with newly diagnosed epilepsy[26].LTG and PHT(phenytoin)monotherapy were similarly effective against these seizure types in patients with newly diagnosed epilepsy and LTG was better tolerated,more frequently causing rash,but with a lower incidence of central nervous system side effects in Steiner TJ's study[27].Coppola G et al also compared valproic acid with LTG,they also found VPA and LTG can be efficacious against absence seizures[28].Among so many antiepileptics,LTG doesn't have the best efficacy and tolerability among all the studies with newly diagnosed epilepsy.However,it is effective and well tolerated compared with placebo[29].And among all the first-line therapy for newly diagnosed epilepsy,especially CBZ,LTG is more effective and tolerated.The reason we chose CBZ as compare was its wide acceptance and there was relatively enough trails for us to take this meta-analysis.All other studies compared LTG with other antiepileptic need more evidences.

    Our results cannot be extrapolated to patients with some concrete epilepsy and not newly diagnosed epilepsy,even some kinds of newly diagnosed epilepsy.There is clearly a need for studies in such patients.Then,we don't find a way to eliminate the high heterogeneity.Thirdly,we failed to contact some authors and didn't get the data.

    5 Conclusions

    LTG has the same efficacy and better tolerability compared with CBP.This is more obvious in the elderly patients.And LTG can be considered as the first-line therapy for the newly diagnosed epilepsy,especially for the elderly.

    【Reference】

    [1]Moher D,Cook DJ,Eastwood S,et al.Improving the quality of reports of meta-analyses of randomised controlled trials:the QUOROM statement.Quality of Reporting of Meta-analyses[J].Lancet,1999,354(9193):1896-1900.

    [2]Bero L,Rennie D.The Cochrane Collaboration.Preparing,maintaining,and disseminating systematic reviews of the effects of health care [J].JAMA,1995,274(24):1935-1938.

    [3]Brodie MJ,Overstall PW,Giorgi L.Multicentre,double-blind,randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy.The UK Lamotrigine Elderly Study Group[J].Epilepsy Res,1999,37(1):81-87.

    [4]Brodie MJ,Richens A,Yuen AW.Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy.UK Lamotrigine/Carbamazepine Monotherapy Trial Group[J].Lancet,1995,345(8948):476-479.

    [5]Gilad R,Sadeh M,Rapoport A,et al.Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure[J].Clin Neuropharmacol,2007,30(4):189-195.

    [6]Lee SA,Lee HW,Heo K,et al.Cognitive and behavioral effects of lamotrigine and carbamazepine monotherapy in patients with newly diagnosed or untreated partial epilepsy[J].Seizure,2011,20(1):49 -54.

    [7]Nieto-Barrera M,Brozmanova M,Capovilla G,et al.A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy[J].Epilepsy Res,2001,46(2):145-155.

    這天晚上,阿東一直坐在床邊,看著阿里睡著。他心里很難過,不知道怎樣才能安慰阿里,也不知道怎樣才能幫到阿里。

    [8]Reunanen M,Dam M,Yuen AW.A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy[J].Epilepsy Res,1996,23(2):149-155.

    [9]Rowan AJ,Ramsay RE,Collins JF,et al.New onset geriatric epilepsy:a randomized study of gabapentin,lamotrigine,and carbamazepine[J].Neurology,2005,64(11):1868-1873.

    [10]Saetre E,Perucca E,Isojarvi J,et al.An international multicenter randomized double-blind controlled trial of lamotrigine and sustainedrelease carbamazepine in the treatment of newly diagnosed epilepsy in the elderly[J].Epilepsia,2007,48(7):1292-1302.

    [11]Steinhoff BJ,Ueberall MA,Siemes H,et al.The LAM-SAFE Study:lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults[J].Seizure,2005,14(8):597-605.

    [12]Jadad AR,Moore RA,Carroll D,et al.Assessing the quality of reports of randomized clinical trials:is blinding necessary?[J].Control Clin Trials,1996,17(1):1-12.

    [13]Egger M,Davey Smith G,Schneider M,et al.Bias in meta-analysis detected by a simple,graphical test[J].BMJ,1997,315(7109):629-634.

    [14]Selim MF,Elnabtity AM,Hasan AM.Comparative evaluation of epidural bupivacaine-dexmedetomidine and bupivacaine-fentanyl on Doppler velocimetry of uterine and umbilical arteries during labor[J].J Prenat Med,2012,6(3):47-54.

    [15]Brodie MJ,Overstall PW,Giorgi L,et al.Multicenter double-blind randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy[J].Epilepsy Res,1999,37:81-87.

    [16]Posner J,Holdich T,Crome P.Comparison of lamotrigine pharmacokinetics in young and elderly healthy volunteers[J].J Pharm Med,1991,1:121-128.

    [17]Bonnett L,Smith CT,Smith D,et al.Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy:post-hoc,subgroup analyses of data from the SANAD trial[J].Lancet Neurol,2012,11(4):331-340.

    [18]Saetre E,Abdelnoor M,Perucca E,et al.Antiepileptic drugs and quality of life in the elderly:results from a randomized double-blind trial of carbamazepine and lamotrigine in patients with onset of epilepsy in old age[J].Epilepsy Behav,2010,17(3):395-401.

    [19]Gillham R,Kane K,Bryant-Comstock L,et al.A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure[J].Seizure,2000,9(6):375-379.

    [20]Saetre E,Abdelnoor M,Amlie JP,et al.Cardiac function and antiepileptic drug treatment in the elderly:a comparison between lamotrigine and sustained-release carbamazepine[J].Epilepsia,2009,50(8):1841-1849.

    [21]Hussein Z,Posner J.Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy:retrospective analysis of routine monitoring data[J].Br J Clin Pharmacol,1997,43(5):457-465.

    [22]Rosenow F,Schade-Brittinger C,Burchardi N,et al.The LaLiMo Trial:lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epil epsy an open-label,prospective,randomised controlled multicenter study[J].J Neurol Neurosurg Psychiatry,2012,83(11):1093-1098.

    [23]Kwan P,Brodie MJ,Kalviainen R,et al.Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures:a phase 3,double-blind,randomised,parallel-group trial[J].Lancet Neurol,2011,10(10):881-890.

    [24]Glauser TA,Cnaan A,Shinnar S,et al.Ethosuximide,valproic acid,and lamotrigine in childhood absence epilepsy[J].N Engl J Med,2010,362(9):790-799.

    [25]Stephen LJ,Sills GJ,Leach JP,et al.Sodium valproate versus lamotrigine:a randomised comparison of efficacy,tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy[J].Epilepsy Res,2007,75(2-3):122-129.

    [26]Brodie MJ,Chadwick DW,Anhut H,et al.Gabapentin versus lamotrigine monotherapy:a double-blind comparison in newly diagnosed epilepsy[J].Epilepsia,2002,43(9):993-1000.

    [27]Steiner TJ,Dellaportas CI,F(xiàn)indley LJ,et al.Lamotrigine monotherapy in newly diagnosed untreated epilepsy:a double-blind comparison with phenytoin[J].Epilepsia,1999,40(5):601-607.

    [28]Coppola G,Auricchio G,F(xiàn)ederico R,et al.Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures:an open-label,randomized,parallel-group study[J].Epilepsia,2004,45(9):1049-1053.

    [29]Frank LM,Enlow T,Holmes GL,et al.Lamictal(lamotrigine)monotherapy for typical absence seizures in children[J].Epilepsia,1999,40(7):973-979.

    2095-6894(2014)06-029-07

    2014-04-23;接受時間:2014-05-19

    Hu Wei,Student Brigade,F(xiàn)ourth Military Medical University of PLA,Xi'an,China.Tel:029-84774504 E-mail:xun1ta@sina.com

    猜你喜歡
    阿東床邊阿里
    云上阿里
    炎黃地理(2021年1期)2021-06-08 00:27:03
    辰辰帶你游阿里
    常識:阿東的衣服
    孩子(2019年10期)2019-11-22 08:06:01
    不殺之恩
    百花園(2019年3期)2019-09-10 07:22:44
    假如我有一個夢
    Interaction of β-Cyclodextrin Catalyst with p-Chlorobenzonitrile for the Synthesis of 5-Substituted 1H-tetrazoles in n,n-Dimethylformamide: a DFT Study①
    床邊急診腹膜透析治療橫紋肌溶解綜合征并發(fā)急性腎功能衰竭的護理體會
    阿東的婚事
    故事會(2017年12期)2017-06-22 23:40:40
    阿里戰(zhàn)略
    床邊血液灌流聯(lián)合血漿置換治療重度蘑菇中毒效果
    午夜福利视频精品| 欧美日韩av久久| 女人被躁到高潮嗷嗷叫费观| 亚洲,欧美精品.| 亚洲第一区二区三区不卡| 日本午夜av视频| 激情五月婷婷亚洲| 人妻系列 视频| 精品亚洲乱码少妇综合久久| 99视频精品全部免费 在线| 26uuu在线亚洲综合色| 久久热在线av| 韩国av在线不卡| 亚洲精品久久成人aⅴ小说| 日韩熟女老妇一区二区性免费视频| 日本av免费视频播放| 亚洲欧洲精品一区二区精品久久久 | 午夜免费男女啪啪视频观看| 交换朋友夫妻互换小说| 国产精品三级大全| 少妇熟女欧美另类| 午夜福利,免费看| 国产福利在线免费观看视频| 亚洲精品色激情综合| 久久午夜福利片| 久久久久久久国产电影| 久久韩国三级中文字幕| 久久精品国产a三级三级三级| 成年人免费黄色播放视频| 在线观看免费日韩欧美大片| 免费久久久久久久精品成人欧美视频 | 成年av动漫网址| 不卡视频在线观看欧美| 成人手机av| 国国产精品蜜臀av免费| 少妇熟女欧美另类| 热99久久久久精品小说推荐| 日本与韩国留学比较| 成人影院久久| 婷婷成人精品国产| videosex国产| 最近最新中文字幕免费大全7| 久久午夜福利片| 高清毛片免费看| 亚洲国产日韩一区二区| 精品国产一区二区久久| 午夜福利影视在线免费观看| av在线老鸭窝| 午夜福利网站1000一区二区三区| 夫妻午夜视频| 亚洲人与动物交配视频| 久久这里有精品视频免费| 国产女主播在线喷水免费视频网站| 国产一区亚洲一区在线观看| 熟女人妻精品中文字幕| 熟女av电影| 欧美日韩成人在线一区二区| 视频中文字幕在线观看| 成年av动漫网址| 久久久久久久久久久免费av| 国产成人免费观看mmmm| 国产精品嫩草影院av在线观看| 国产亚洲精品第一综合不卡 | 欧美精品亚洲一区二区| 亚洲欧美成人精品一区二区| 日本色播在线视频| 91精品国产国语对白视频| 中文字幕亚洲精品专区| 美女脱内裤让男人舔精品视频| 国产国语露脸激情在线看| av卡一久久| 亚洲美女搞黄在线观看| 亚洲第一区二区三区不卡| 精品午夜福利在线看| www日本在线高清视频| 天天影视国产精品| 亚洲精品日韩在线中文字幕| 最近中文字幕高清免费大全6| 久热久热在线精品观看| 久久国产精品大桥未久av| 亚洲国产精品专区欧美| 色婷婷久久久亚洲欧美| 色5月婷婷丁香| 成人手机av| 免费观看性生交大片5| 18禁动态无遮挡网站| 大香蕉久久网| 爱豆传媒免费全集在线观看| 少妇人妻精品综合一区二区| 日本黄色日本黄色录像| 国产精品国产三级国产av玫瑰| 国产亚洲精品久久久com| 国产成人精品一,二区| 国产免费一级a男人的天堂| 久久人人爽人人爽人人片va| 久久久久国产精品人妻一区二区| 捣出白浆h1v1| 亚洲成国产人片在线观看| 中文乱码字字幕精品一区二区三区| 日韩电影二区| 国产一区二区三区av在线| 啦啦啦中文免费视频观看日本| 纯流量卡能插随身wifi吗| 久久久国产精品麻豆| 精品久久久久久电影网| 人妻少妇偷人精品九色| 99国产精品免费福利视频| 日韩中字成人| 亚洲综合精品二区| 国产精品国产av在线观看| 18在线观看网站| 天堂8中文在线网| 香蕉精品网在线| 免费av不卡在线播放| 七月丁香在线播放| 国产乱来视频区| 欧美激情国产日韩精品一区| 成人国语在线视频| 9热在线视频观看99| 一区二区日韩欧美中文字幕 | a级毛片黄视频| 男女无遮挡免费网站观看| 男女边摸边吃奶| 青春草亚洲视频在线观看| 免费看av在线观看网站| 中文字幕另类日韩欧美亚洲嫩草| 国产高清国产精品国产三级| 国产欧美日韩一区二区三区在线| 大话2 男鬼变身卡| 久久综合国产亚洲精品| 中文字幕免费在线视频6| 老司机影院毛片| 精品久久蜜臀av无| 麻豆乱淫一区二区| 成人亚洲欧美一区二区av| 少妇的丰满在线观看| 午夜激情av网站| 欧美人与善性xxx| 免费在线观看黄色视频的| 午夜福利影视在线免费观看| 一区二区日韩欧美中文字幕 | 最近2019中文字幕mv第一页| videosex国产| 国产片内射在线| 久热久热在线精品观看| 国产福利在线免费观看视频| 亚洲,一卡二卡三卡| 丁香六月天网| 欧美日韩成人在线一区二区| 最近手机中文字幕大全| 久久毛片免费看一区二区三区| 国产精品一国产av| 王馨瑶露胸无遮挡在线观看| 赤兔流量卡办理| 波多野结衣一区麻豆| av卡一久久| 国产精品麻豆人妻色哟哟久久| 亚洲一区二区三区欧美精品| 亚洲高清免费不卡视频| 亚洲人成网站在线观看播放| 日本wwww免费看| 国内精品宾馆在线| 成年人免费黄色播放视频| 色吧在线观看| 啦啦啦啦在线视频资源| 亚洲欧美精品自产自拍| 亚洲精品久久午夜乱码| 99re6热这里在线精品视频| 草草在线视频免费看| av女优亚洲男人天堂| 亚洲性久久影院| 菩萨蛮人人尽说江南好唐韦庄| 国产老妇伦熟女老妇高清| 国产不卡av网站在线观看| 99热国产这里只有精品6| 一本大道久久a久久精品| 精品一区二区三卡| 中文欧美无线码| 亚洲婷婷狠狠爱综合网| 国产又色又爽无遮挡免| www.色视频.com| 成年人午夜在线观看视频| 色5月婷婷丁香| www.色视频.com| 午夜激情av网站| 免费大片黄手机在线观看| 久久久久精品久久久久真实原创| 狂野欧美激情性bbbbbb| 九九在线视频观看精品| 亚洲国产精品一区三区| 巨乳人妻的诱惑在线观看| 超色免费av| 美女福利国产在线| kizo精华| 人人妻人人澡人人看| 国产精品久久久久久精品电影小说| 91精品三级在线观看| 七月丁香在线播放| 欧美亚洲日本最大视频资源| 精品人妻偷拍中文字幕| 午夜91福利影院| 亚洲人成网站在线观看播放| 国产一区亚洲一区在线观看| 欧美成人午夜免费资源| 日本与韩国留学比较| 夜夜骑夜夜射夜夜干| 亚洲,欧美精品.| 99热网站在线观看| 国产精品国产三级国产专区5o| 久久狼人影院| 精品久久久久久电影网| 成人二区视频| 22中文网久久字幕| 国产成人a∨麻豆精品| 亚洲丝袜综合中文字幕| 成人国语在线视频| 成人漫画全彩无遮挡| 男女午夜视频在线观看 | 如日韩欧美国产精品一区二区三区| 一级黄片播放器| 亚洲精品美女久久av网站| 亚洲精品色激情综合| 蜜桃国产av成人99| 亚洲av中文av极速乱| 久久精品国产综合久久久 | 久久ye,这里只有精品| 九九爱精品视频在线观看| 国产精品 国内视频| 看免费av毛片| 国产不卡av网站在线观看| 少妇人妻久久综合中文| 欧美亚洲日本最大视频资源| 婷婷色麻豆天堂久久| av国产久精品久网站免费入址| 成年女人在线观看亚洲视频| 女人精品久久久久毛片| 中文字幕制服av| 美女大奶头黄色视频| 嫩草影院入口| 成年人免费黄色播放视频| 男女边吃奶边做爰视频| 国产日韩欧美在线精品| 亚洲伊人久久精品综合| 亚洲精品国产av蜜桃| 久久久亚洲精品成人影院| 99九九在线精品视频| 日韩成人伦理影院| 啦啦啦在线观看免费高清www| 飞空精品影院首页| 只有这里有精品99| 国产日韩欧美视频二区| 国产av精品麻豆| 亚洲精品久久午夜乱码| 国产伦理片在线播放av一区| 色哟哟·www| 亚洲av在线观看美女高潮| 最新的欧美精品一区二区| 亚洲精品国产av成人精品| 日本黄色日本黄色录像| 久久人人爽av亚洲精品天堂| 欧美变态另类bdsm刘玥| 国产激情久久老熟女| 韩国精品一区二区三区 | 亚洲伊人色综图| 国产黄频视频在线观看| 久久精品夜色国产| 在线看a的网站| 在线观看免费高清a一片| 热99久久久久精品小说推荐| 色哟哟·www| 乱码一卡2卡4卡精品| 欧美人与性动交α欧美精品济南到 | 国产精品久久久久久av不卡| 久久久久国产网址| 黄片播放在线免费| 亚洲人成网站在线观看播放| 亚洲欧洲日产国产| 久久婷婷青草| 在线观看三级黄色| 国产精品久久久av美女十八| 美女国产视频在线观看| 内地一区二区视频在线| 亚洲美女黄色视频免费看| 水蜜桃什么品种好| 天天操日日干夜夜撸| 亚洲成人手机| videosex国产| 在线观看免费高清a一片| 亚洲性久久影院| 国产亚洲午夜精品一区二区久久| 天天影视国产精品| 黑人高潮一二区| 久久精品国产亚洲av天美| 国产精品一国产av| 久久久精品区二区三区| 欧美精品一区二区大全| 亚洲av免费高清在线观看| 国产白丝娇喘喷水9色精品| 国产精品女同一区二区软件| 国产伦理片在线播放av一区| 在线观看国产h片| 亚洲三级黄色毛片| 久久人人爽人人爽人人片va| 久久国产精品男人的天堂亚洲 | 秋霞伦理黄片| 亚洲内射少妇av| 极品少妇高潮喷水抽搐| 亚洲伊人久久精品综合| 国产在线一区二区三区精| 婷婷色综合大香蕉| 欧美成人精品欧美一级黄| 丝袜人妻中文字幕| 婷婷色综合www| 女性生殖器流出的白浆| 国产成人a∨麻豆精品| 精品少妇黑人巨大在线播放| 国产精品女同一区二区软件| 欧美老熟妇乱子伦牲交| 中国国产av一级| 日韩一区二区视频免费看| 爱豆传媒免费全集在线观看| 久久久久久久亚洲中文字幕| 最近最新中文字幕免费大全7| av福利片在线| 欧美日韩亚洲高清精品| 精品国产乱码久久久久久小说| 婷婷色av中文字幕| 欧美日韩视频精品一区| 丝袜在线中文字幕| 久久精品国产自在天天线| 亚洲av综合色区一区| 欧美亚洲 丝袜 人妻 在线| 午夜激情av网站| 国产免费一级a男人的天堂| 又黄又粗又硬又大视频| 国产av码专区亚洲av| 美女福利国产在线| 欧美最新免费一区二区三区| 成人无遮挡网站| 日韩熟女老妇一区二区性免费视频| 精品少妇久久久久久888优播| 欧美激情 高清一区二区三区| 激情五月婷婷亚洲| 宅男免费午夜| 黑人欧美特级aaaaaa片| 人人妻人人爽人人添夜夜欢视频| 日韩成人av中文字幕在线观看| 日韩成人伦理影院| 色视频在线一区二区三区| 熟女av电影| 中文字幕最新亚洲高清| 欧美变态另类bdsm刘玥| 高清av免费在线| 精品一区二区三卡| 免费av中文字幕在线| 精品视频人人做人人爽| 多毛熟女@视频| 久久精品aⅴ一区二区三区四区 | 中文字幕av电影在线播放| 久久鲁丝午夜福利片| 久久99热这里只频精品6学生| 在线精品无人区一区二区三| xxxhd国产人妻xxx| 国产一区二区激情短视频 | 乱人伦中国视频| 久久这里只有精品19| 中文字幕制服av| 中文字幕人妻熟女乱码| 久久人人97超碰香蕉20202| 精品国产乱码久久久久久小说| 久久久久久久大尺度免费视频| 欧美精品一区二区免费开放| 欧美成人精品欧美一级黄| 哪个播放器可以免费观看大片| 亚洲精品中文字幕在线视频| av福利片在线| 精品亚洲乱码少妇综合久久| 久久久久视频综合| h视频一区二区三区| 色哟哟·www| av视频免费观看在线观看| 男女国产视频网站| 欧美人与善性xxx| 天美传媒精品一区二区| 精品酒店卫生间| av卡一久久| 久久国产精品大桥未久av| 欧美日韩国产mv在线观看视频| 99精国产麻豆久久婷婷| 国产亚洲精品久久久com| 亚洲欧美精品自产自拍| 最近2019中文字幕mv第一页| av播播在线观看一区| 蜜桃国产av成人99| 日本wwww免费看| 极品少妇高潮喷水抽搐| 亚洲综合色网址| 久久精品aⅴ一区二区三区四区 | 美国免费a级毛片| 日本免费在线观看一区| 美女国产高潮福利片在线看| 亚洲精品自拍成人| 国产一级毛片在线| 精品国产一区二区久久| 国产精品久久久av美女十八| 久久久精品94久久精品| 99国产精品免费福利视频| av在线播放精品| 精品酒店卫生间| 99九九在线精品视频| 欧美日韩一区二区视频在线观看视频在线| 国产老妇伦熟女老妇高清| 日韩人妻精品一区2区三区| 一边摸一边做爽爽视频免费| 亚洲色图 男人天堂 中文字幕 | 久久99蜜桃精品久久| 亚洲国产欧美日韩在线播放| 精品一区二区三区四区五区乱码 | 人人妻人人澡人人看| av黄色大香蕉| 免费久久久久久久精品成人欧美视频 | 亚洲av欧美aⅴ国产| 在现免费观看毛片| 午夜日本视频在线| 晚上一个人看的免费电影| 最新中文字幕久久久久| 精品亚洲成国产av| 亚洲欧洲日产国产| 99国产精品免费福利视频| 卡戴珊不雅视频在线播放| 免费av不卡在线播放| 欧美人与性动交α欧美软件 | 飞空精品影院首页| 亚洲av.av天堂| 亚洲第一av免费看| 久久ye,这里只有精品| 久久精品国产亚洲av涩爱| 美女福利国产在线| 久久99一区二区三区| 亚洲精品第二区| 日本与韩国留学比较| 18禁观看日本| 五月玫瑰六月丁香| 日韩在线高清观看一区二区三区| 免费观看无遮挡的男女| 日本-黄色视频高清免费观看| 亚洲欧美中文字幕日韩二区| 最新的欧美精品一区二区| 飞空精品影院首页| 国产精品国产三级国产av玫瑰| 午夜福利乱码中文字幕| 视频中文字幕在线观看| 亚洲成人av在线免费| 国内精品宾馆在线| 国产精品国产三级专区第一集| 国产精品蜜桃在线观看| 亚洲av男天堂| 考比视频在线观看| 亚洲欧美日韩卡通动漫| 国产精品久久久久久久电影| 国产成人aa在线观看| 国产午夜精品一二区理论片| 22中文网久久字幕| 热re99久久精品国产66热6| 国产欧美日韩综合在线一区二区| 乱码一卡2卡4卡精品| 菩萨蛮人人尽说江南好唐韦庄| 国产色婷婷99| 久久久久人妻精品一区果冻| 黄色一级大片看看| 日韩免费高清中文字幕av| 母亲3免费完整高清在线观看 | 高清在线视频一区二区三区| 国产男人的电影天堂91| 欧美老熟妇乱子伦牲交| 国产免费视频播放在线视频| 久久人妻熟女aⅴ| 少妇人妻精品综合一区二区| 99香蕉大伊视频| 精品亚洲成国产av| 男女国产视频网站| 岛国毛片在线播放| 99久国产av精品国产电影| 亚洲精品视频女| 午夜精品国产一区二区电影| 桃花免费在线播放| 80岁老熟妇乱子伦牲交| 免费观看性生交大片5| 香蕉丝袜av| 最近2019中文字幕mv第一页| 五月伊人婷婷丁香| av在线老鸭窝| 久久久久人妻精品一区果冻| 成人亚洲精品一区在线观看| 五月天丁香电影| 91aial.com中文字幕在线观看| 97在线人人人人妻| 丰满乱子伦码专区| 亚洲中文av在线| 亚洲情色 制服丝袜| 伦理电影大哥的女人| 女性被躁到高潮视频| 中文欧美无线码| 精品亚洲成a人片在线观看| 多毛熟女@视频| 欧美激情极品国产一区二区三区 | 黄片无遮挡物在线观看| 久久精品国产a三级三级三级| 一级a做视频免费观看| 亚洲国产日韩一区二区| 亚洲av免费高清在线观看| 国产黄频视频在线观看| 男女午夜视频在线观看 | 国产精品一区二区在线观看99| av女优亚洲男人天堂| 免费观看a级毛片全部| 在线观看一区二区三区激情| 9色porny在线观看| 99视频精品全部免费 在线| 免费黄色在线免费观看| 国产极品粉嫩免费观看在线| 日韩电影二区| 久久精品久久精品一区二区三区| 肉色欧美久久久久久久蜜桃| 国产69精品久久久久777片| 亚洲av男天堂| 97超碰精品成人国产| 美女内射精品一级片tv| 欧美精品人与动牲交sv欧美| 久久久久久久大尺度免费视频| 啦啦啦在线观看免费高清www| 十八禁网站网址无遮挡| 免费日韩欧美在线观看| 亚洲美女黄色视频免费看| av在线老鸭窝| 国产成人av激情在线播放| 狠狠婷婷综合久久久久久88av| 建设人人有责人人尽责人人享有的| 亚洲av男天堂| 亚洲,欧美精品.| 夜夜骑夜夜射夜夜干| 日本与韩国留学比较| 丝袜喷水一区| 观看美女的网站| 制服丝袜香蕉在线| 国产一级毛片在线| 大片电影免费在线观看免费| www.av在线官网国产| 精品一区二区三区视频在线| 少妇被粗大猛烈的视频| 午夜福利乱码中文字幕| 国产成人a∨麻豆精品| 午夜福利在线观看免费完整高清在| 热re99久久精品国产66热6| 国产欧美另类精品又又久久亚洲欧美| 精品少妇黑人巨大在线播放| 久久久久网色| 免费播放大片免费观看视频在线观看| 午夜视频国产福利| 18禁在线无遮挡免费观看视频| 国产极品天堂在线| 久久久国产欧美日韩av| 黑人欧美特级aaaaaa片| 亚洲欧美一区二区三区黑人 | 黄色一级大片看看| 亚洲人与动物交配视频| 色婷婷av一区二区三区视频| 国产精品不卡视频一区二区| 久久国内精品自在自线图片| 69精品国产乱码久久久| 成年女人在线观看亚洲视频| 大片免费播放器 马上看| 欧美日韩成人在线一区二区| 亚洲欧美色中文字幕在线| 91在线精品国自产拍蜜月| 男的添女的下面高潮视频| 老熟女久久久| 亚洲国产精品一区三区| 寂寞人妻少妇视频99o| 久久久久久久国产电影| 亚洲精品国产色婷婷电影| 大陆偷拍与自拍| 久久99热6这里只有精品| 在线观看三级黄色| 久久久久久久久久久免费av| 三级国产精品片| 各种免费的搞黄视频| 日韩,欧美,国产一区二区三区| 国内精品宾馆在线| 国产国语露脸激情在线看| 日韩在线高清观看一区二区三区| 国产精品久久久久成人av| 亚洲天堂av无毛| 在线观看免费视频网站a站| 99九九在线精品视频| 亚洲色图 男人天堂 中文字幕 | 亚洲成国产人片在线观看| 看免费成人av毛片| 免费黄色在线免费观看| 久久久久视频综合| 女性生殖器流出的白浆| 99热这里只有是精品在线观看| 黑人高潮一二区| 国产白丝娇喘喷水9色精品| 99热这里只有是精品在线观看| 欧美精品国产亚洲| 久久精品人人爽人人爽视色| 久久精品久久久久久久性| 久久久国产一区二区| 成人亚洲欧美一区二区av| 丝袜在线中文字幕| 伦理电影免费视频| 天堂中文最新版在线下载| 欧美成人午夜免费资源| 在线观看美女被高潮喷水网站|